Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 11 % of short-term debt in 2025; threshold 65 %.
-
Shrinking team NBB
FTE fell two years in a row, from 30.8 to 21.1.
-
Busy address KBO
12 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
BIOMEDICAL DISTRIBUTION BELGIUM from Sint-Lambrechts-Woluwe, company number BE0724560504, closed financial year 2025 with a result of € -2.5 million after tax. For that financial year BIOMEDICAL DISTRIBUTION BELGIUM recorded a gross margin of € 102,106 and equity of € -4.9 million. Compared with financial year 2024, the result moved from € -994,752 to € -2.5 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 14, 2026.
€ -4.9 million
▼ € 2.5 million vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -2.5 million
▼ 154 % more loss than in 2024
Profit after tax over the fiscal year.
Loss, nothing to pay out
Reserves fell to € -4.9 million.
People and assets in 2025
21.1
▼ 9.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 1.7 million
▼ 12% vs 2024
€ 82,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 21,895
▼ 75% vs 2024
Of which on lease € 21,895.
Debts at end 2025
€ 3,722
▼ 97% vs 2024
Loans from banks and other lenders, long and short.
€ 17,522
▼ 75% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 190,087
▼ 25% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 606,051 | € 1,316,999 | € 1,296,561 | € 102,106 | ▼ 92% |
| Profit after taxes | € -346,141 | € -754,686 | € -994,752 | € -2,524,639 | ▼ € 1.5 million |
| Equity | € -635,013 | € -1,389,699 | € -2,384,451 | € -4,909,090 | ▼ € 2.5 million |
| Total debts | € 1,944,120 | € 2,460,842 | € 3,584,772 | € 4,963,486 | ▲ 38% |
| Cash | € 193,969 | € 44,284 | € 0 | - | |
| Retained profit | € -653,563 | € -1,408,249 | € -2,403,001 | € -4,927,640 | ▼ € 2.5 million |
| Bank debt | € 385,829 | € 201,554 | € 118,306 | € 3,722 | ▼ 97% |
| Balance sheet total | € 1,309,106 | € 1,071,143 | € 1,200,321 | € 637,812 | ▼ 47% |
| Employees (FTE) | 12.8 | 30.8 | 30.3 | 21.1 | ▼ 9.2 |
Key figures of BIOMEDICAL DISTRIBUTION BELGIUM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to BIOMEDICAL DISTRIBUTION BELGIUM?
What happened at BIOMEDICAL DISTRIBUTION BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Alen Voskericyan stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 2.5 million. Source: NBB ↗
- Britta Weber stepped down as director. NBB
- Andrew Sleiman became a director. NBB
- Peter Raoul Stewardson stepped down as director. NBB
- Britta Weber became a director. NBB
- Alen Voskericyan became a director. NBB
- William Jacques became a director. NBB
In short
From € 346,141 loss in 2022 to € 2.5 million loss in 2025.
Paid € 415 in corporate taxes since 2022.
On average € 4,800 of value added per employee in 2025.
A new publication or filing at BIOMEDICAL DISTRIBUTION BELGIUM? We notify you, reason included.
Follow BIOMEDICAL DISTRIBUTION BELGIUMDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind BIOMEDICAL DISTRIBUTION BELGIUM are Andrew Sleiman and William Jacques.
Directors
According to the 2025 annual accounts
Andrew Sleiman
Director
since 2026
William Jacques
Director
since 2023
Britta Weber
Director
since 2025 · until 2026
Alen Voskericyan
Director
since 2024 · until 2030
Peter Raoul Stewardson
Director
since 2023 · until 2025
Establishments
Establishment units
Physical locations of this company
Arianelaan 5
1200 Sint-Lambrechts-Woluwe
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 12 companies are registered at this address.
All companies at this address →ENTREMONT BENELUX
€ 2.1 million gross margin · 2023
CENTRE D'ANATOMIE PATHOLOGIQUE et de CYTOLOGIE
€ 1.2 million gross margin · 2025
Sewan Belgium
€ 9.7 million revenue · 2025
SARTORIUS BELGIUM
€ 3.6 million revenue · 2025
UPS EUROPE
€ 592 million revenue · 2024
+7 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0724.560.504
- VAT number
- BE 0724.560.504
- Registered office
- Arianelaan 5, 1200 Sint-Lambrechts-Woluwe
- Names & denominations
- BIOMEDICAL DISTRIBUTION BELGIUM · BOMI BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 April 2019
- Peppol
- Active · Active since 29 Jan 2026
- Activities · NACE
Logistieke diensten
Opslag
Overige vervoerondersteunende activiteiten
Overige vrachtbehandeling, exclusief in zeehavens
Diensten in verband met vervoer te land
Diensten in verband met vervoer over water